FRAT1 peptide decreases Abeta production in swAPP(751) cells.
about
Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeuticsSelectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease.Inhibition of glycogen synthase kinase-3 ameliorates β-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studiesNeurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.GSK3 as a Sensor Determining Cell Fate in the Brain.Inorganic polyphosphate promotes cyclin D1 synthesis through activation of mTOR/Wnt/β-catenin signaling in endothelial cells.
P2860
FRAT1 peptide decreases Abeta production in swAPP(751) cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
FRAT1 peptide decreases Abeta production in swAPP
@nl
FRAT1 peptide decreases Abeta production in swAPP(751) cells.
@en
type
label
FRAT1 peptide decreases Abeta production in swAPP
@nl
FRAT1 peptide decreases Abeta production in swAPP(751) cells.
@en
prefLabel
FRAT1 peptide decreases Abeta production in swAPP
@nl
FRAT1 peptide decreases Abeta production in swAPP(751) cells.
@en
P2093
P2860
P1433
P1476
FRAT1 peptide decreases Abeta production in swAPP(751) cells.
@en
P2093
P2860
P304
P356
10.1016/S0014-5793(03)01042-1
P407
P577
2003-10-01T00:00:00Z